Back

Select your region

Arrange a consultation about stem cells

Learn more

List of life saving
transplantations

List of uses for stem cells approved by the FamiCord Group’s laboratories:

Image
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
3101 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 54
3102 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 63
3103 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 54
3104 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 71
3105 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 67
3106 Apheresis Allogeneic Chronic Myelomonocytic Leukemia, Type 0 (Cmml-0) Hematology 2022 Standard Therapy Poland 64
3107 Apheresis Allogeneic Chronic Neutrophilic Leukemia Hematology 2022 Standard Therapy Poland 66
3108 Apheresis Allogeneic Chronic Neutrophilic Leukemia Hematology 2022 Standard Therapy Poland 72
3109 Apheresis Allogeneic Combined Immunodeficiency Syndrome With Hyper-Igm Hematology 2022 Standard Therapy Poland 6
3110 Apheresis Allogeneic Congenital Dyserythropoietic Anemia Hematology 2022 Standard Therapy Poland 2
3111 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 68
3112 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 65
3113 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 69
3114 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 50
3115 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 56
3116 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 65
3117 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 47
3118 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2022 Standard Therapy Germany 66
3119 Apheresis Autologous Diffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic Leukemia Hematology 2022 Standard Therapy Germany 66
3120 Apheresis Autologous Germ Cell Tumor Hematology 2022 Standard Therapy Germany 39
3121 Apheresis Autologous Germ Cell Tumor Hematology 2022 Standard Therapy Germany 33
3122 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis (Hlh) Hematology 2022 Standard Therapy Poland 12
3123 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis (Hlh) Hematology 2022 Standard Therapy Poland 21
3124 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 26
3125 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 31
3126 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 53
3127 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 25
3128 Apheresis Autologous Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 67
3129 Apheresis Autologous Hodgkin Lymphoma-Relapse Hematology 2022 Standard Therapy Germany 69
3130 Apheresis Autologous Hodgkin Lymphoma-Relapse Hematology 2022 Standard Therapy Germany 48
3131 Apheresis Allogeneic Hypoplastic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 26
3132 Apheresis Allogeneic Immunodeficiency Hematology 2022 Standard Therapy Poland 3
3133 Apheresis Allogeneic Juvenile Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 5
3134 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 64
3135 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 61
3136 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 52
3137 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 44
3138 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 53
3139 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 49
3140 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 64
3141 Apheresis Allogeneic Mixed Phenotype Acute Leukemia Hematology 2022 Standard Therapy Poland 64
3142 Apheresis Autologous Morbus Hodgkin Hematology 2022 Standard Therapy Germany 36
3143 Apheresis Autologous Morbus Hodgkin Hematology 2022 Standard Therapy Germany 62
3144 Apheresis Autologous Morbus Hodgkin-Relapse Hematology 2022 Standard Therapy Germany 63
3145 Apheresis Allogeneic Mucopolysaccharidosis Hematology 2022 Standard Therapy Poland 2
3146 Apheresis Allogeneic Mucopolysaccharidosis Type I Hematology 2022 Standard Therapy Poland 3
3147 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 58
3148 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 53
3149 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 57
3150 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 64
3151 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 50
3152 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 67
3153 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 55
3154 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 73
3155 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 63
3156 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 65
3157 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 58
3158 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 37
3159 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 47
3160 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 68
3161 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 53
3162 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 60
3163 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 60
3164 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 47
3165 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 59
3166 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 64
3167 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 59
3168 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 52
3169 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 73
3170 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 68
3171 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 63
3172 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 66
3173 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 50
3174 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 69
3175 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 57
3176 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 55
3177 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 61
3178 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 64
3179 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 71
3180 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 61
3181 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 62
3182 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 60
3183 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 33
3184 Apheresis Allogeneic Multiple Myeloma – Relapse Hematology 2022 Standard Therapy Germany 43
3185 Apheresis Autologous Multiple Myeloma Angioimmunoblastic T-Cell Lymphoma Hematology 2022 Standard Therapy Germany 62
3186 Apheresis Allogeneic Mycosis Fungoides Hematology 2022 Standard Therapy Poland 64
3187 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
3188 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 69
3189 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 76
3190 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 45
3191 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 63
3192 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 72
3193 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 70
3194 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 45
3195 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 73
3196 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 21
3197 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 46
3198 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
3199 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
3200 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 49